UK healthcare deploys drones for quick delivery of cancer drugs – Times of India

London: UK National Health Service ,NHS) celebrates its 74th birthday on Tuesday, with the announcement of a revolutionary test to cut down on delivery times cancer drugs by its use drone technology,
The drone, ready to make its first flight in the coming weeks, will mean life-saving chemotherapy treatments can be picked up and dropped off patients on the same day.
In the first trial of its kind, starting on the Isle of Wight in coastal England, the chemo will be sent directly from a pharmacy at the University of Portsmouth Hospital NHS Trust to St Mary’s Hospital, where staff will collect it before it is distributed. Hospital teams and patients.
NHS Chief Executive Amanda Pritchard said: “Drone delivery of chemo to cancer patients is another extraordinary development and shows how the NHS can help people get the treatment they need quickly – as well as to cut costs and carbon emissions. Nothing will stop him.”
“From a smartwatch to managing Parkinson’s to revolutionary prostate treatment and making the world’s most expensive drug available to NHS patients, this has been another wonderful year of innovation in the way healthcare is treated and cared for. As the NHS turns 74, it is clear that the pace of change and improvement in healthcare is only accelerating as our brilliant staff seeks to make life-changing progress to improve the lives of patients, as we have done in the NHS Promised in long term plan.
Chemotherapy is difficult to transport because some doses have a short shelf life, so the NHS has partnered with tech company Appian to find a new way to treat patients in “record time”.
Drones will cut normal delivery times from four hours to 30 minutes, saving fuel and money and making cancer care more convenient for patients living on the Isle of Wight, who are often on the mainland for treatment at this time. travel is required.
“My mother worked for the NHS in Portsmouth her whole life before she died of cancer three years ago,” said Alexander Treby, Appian’s CEO.
“This project is a very important first step in building a network of drone corridors connecting hospitals, pathology labs, GP surgeries, care homes and pharmacies up and down the country so that in the future, mothers of all can benefit from delivery. Fast, smart and green healthcare,” he said.
Each drone delivery replaces at least two car journeys and one hovercraft or ferry trip per delivery – saving on carbon emissions and contributing to improving air quality for patients and the community. It will also help the NHS become the first health system in the world to become carbon neutral, the health service hopes.
The drone program will be tested initially in the Isle of Wight and then in Northumbria in northern England and could allow physicians to place “same-day orders” for critical medical equipment and other treatments.
The trial is a joint effort between Isle of Wight NHS Trust, University of Portsmouth Hospital NHS Trust, Solent Transport, University of Southampton, King’s College London, Skylift, Modini, Ministry of Defence. UK Research Institute (UKRI) and Appian.
The NHS in its long-term plan has committed to deploying the latest cutting-edge technologies while introducing new innovations and treatments to patients across the country.
Earlier this year, the taxpayer-funded healthcare announced that Parkinson’s disease patients would be given life-changing smartwatches that allow doctors to remotely assess their condition in a pioneering project to revolutionize NHS care. allows. The health service has begun treating sickle cell patients with the life-changing drug, a deal thanks to crizanlizumab, which will be offered to up to 5,000 patients within three years.
For patients with advanced and aggressive forms of cancer, the NHS said it has struck a number of deals this year, ranging from a 30-minute treatment for advanced womb cancer called dostarlimumab to a life-extending injection for blood cancer called daratumumab. Is. Extend the lives of patients with recurrent and incurable cancer of the bone marrow cells — known as multiple myeloma — by an average of nine months.